Home › Pfizer, GSK, Sanofi, Others Take Issue with FDA's CMO Draft Guidance
 

Keywords :   


Pfizer, GSK, Sanofi, Others Take Issue with FDA's CMO Draft Guidance

2013-09-24 11:39:23| Biotech - Topix.net

Pfizer, GlaxoSmithKline, Sanofi, and at least ten other big pharma companies, CMOs and industry groups are criticizing aspects of the recent FDA draft guidance governing quality agreements.

Tags: issue draft guidance pfizer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
More »